We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Protein Polymer Technologies (PPTI) announced that its licensee, Spine Wave,
has notified PPTI of its intent to expand European human clinical testing of
NuCore Injectable Disc Nucleus (IDN), an injectable protein polymer formulation
for repair of spinal discs damaged as a result of injury or aging.
Bridgetech Holdings International announced that the company has signed a letter
of intent to form Evit Asia with Evit Labs U.S. to manufacture and distribute
the Sonik LDI 20 portable nebulizer and other inhalation therapy products throughout
Asia.
Medical International Technology, a developer and
manufacturer of patented needle free jet injectors for human and animal inoculation,
announced the sale of 25 of its MED-JET -- MBX low pressure needle-free
injectors designed for anesthetics use to Winsor (Hong Kong).
Toshiba America Medical Systems has introduced a new optimized cardiac configuration
for the Excelart Vantage, the company's 1.5-tesla, high-field magnetic resonance
imaging (MRI) system equipped with one of the shortest magnets in the industry.
The FDA has conducted a review of Biofield's request for reclassification of
the Biofield Breast Proliferation Rate Detection System that is intended as
an adjunct that may support other modalities such as mammography, clinical breast
exam, sonography and magnetic resonance imaging used in breast cancer diagnosis.
Apogee Technology, a global provider of silicon-based innovations for specialized
commercial applications, has signed an agreement with the University of Medicine
and Dentistry New Jersey's (UMDNJ) Laboratory for Drug Delivery to conduct research
and testing on the company's proprietary, MEMS-based transdermal drug delivery
device.
Boston Scientific has completed enrollment in its three-year ENTERYX Procedure
clinical trial, designed to collect and analyze "real-world" clinical
outcomes, and safety and efficacy data on the ENTERYX Procedure for patients
suffering from gastroesophageal reflux disease (GERD) symptoms.
Cholestech announced the introduction of the Cholestech LDX high sensitivity
C-Reactive Protein (hs-CRP) test at the 54th Annual Scientific Session of the
American College of Cardiology.
Fresh off a U.S. Patent and Trademark Office ruling that overturned a patent
related to the collection and preservation of stem cells, ThermoGenesis - which
makes equipment used to store such cells -- has asked the government to
consider rejecting the claims made in two more.
ZymeQuest, a company that discovers, develops and commercializes carbohydrate-modified
blood products for use in transfusion medicine, has exercised its option to
license worldwide rights to a new method of treating platelets developed by
Brigham and Women's Hospital.